Roles of NG2 glial cells in diseases of the central nervous system

Neuroscience Bulletin

Volumn 27, Issue 6, 2011, Pages 413-421

  Xu, Jian Ping ^a   Zhao, Jie ^a   Li, Shao ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Electrophysiology; Epilepsy; Glioma; Multiple sclerosis; NG2 cell

Indexed keywords

PROTEOGLYCAN;

ALZHEIMER DISEASE; CELL FUNCTION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; DEPRESSION; ELECTROCONVULSIVE THERAPY; EPILEPSY; GLIA CELL; GLIOMA; HUMAN; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; OLIGODENDROGLIA; PATHOPHYSIOLOGY; REMYELINIZATION; REVIEW; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY;

ALZHEIMER DISEASE; ANTIGENS; BRAIN; BRAIN DISEASES; BRAIN INJURIES; EPILEPSY; GLIOMA; HUMANS; MULTIPLE SCLEROSIS; NEUROGLIA; PROTEOGLYCANS;

EID: 84862908832     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-011-1838-2     Document Type: Review

References (101)

1. Nishiyama A, Komitova M, Suzuki R, Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 2009, 10(1): 9-22.
2. Levison SW, Young GM, Goldman JE. Cycling cells in the adult rat neocortex preferentially generate oligodendroglia. J Neurosci Res 1999, 57: 435-446. (Pubitemid 29372918)
3. Olivier C, Cobos I, Perez Villegas EM, Spassky N, Zalc B, Martinez S, et al. Monofocal origin of telencephalic oligodendrocytes in the anterior entopeduncular area of the chick embryo. Development 2001, 128: 1757-1769. (Pubitemid 32514856)
4. + glial cells are distinct from resting and activated microglia. J Neurosci Res 1999, 48: 299-312. (Pubitemid 27232704)
5. Komitova M, Zhu X, Serwanski DR, Nishiyama A. NG2 cells are distinct from neurogenic cells in the postnatal mouse subventricular zone. J Comp Neurol 2009, 512(5): 702-716.
6. Kitada M, Rowitch DH. Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord. Glia 2006, 54: 35-46. (Pubitemid 43980032)
7. Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, et al. Development of NG2 neural progenitor cells requires Olig gene function. Proc Natl Acad Sci U S A 2006, 103: 7853-7858.
8. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002, 109: 75-86. (Pubitemid 34327518)
9. Zhou Q, Anderson DJ. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 2002, 109: 61-73. (Pubitemid 34327517)
10. Zhu X, Hill RA, Nishiyama A. NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord. Neuron Glia Biol 2008, 4(1): 19-26.
11. Zhu X, Bergles DE, Nishiyama A. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 2008, 135: 145-157. (Pubitemid 351201488)
12. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G 2nd, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenically dysmyelinated brain. Nature Med 2004, 10: 93-97. (Pubitemid 38524704)
13. Rivers RE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, et al. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 2008, 11: 1392-1401.
14. Buffo A, Rite I, Tripathi P, Lepier A, Colak D, Horn AP, et al. Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain. Proc Natl Acad Sci U S A 2008, 105(9): 3581-3586. (Pubitemid 351723595)
15. Belachew S, Chittajallu R, Aguirre AA, Yuan X, Kirby M, Anderson S, et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 2003, 161: 169-186. (Pubitemid 36459089)
16. Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G 2nd, Jiang L, et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 2003, 9: 439-447. (Pubitemid 36460078)
17. Aguirre A, Gallo V. Postnatal neurogenesis and gliogenesis in the olfactory bulb from NG2-expressing progenitors of the subventricular zone. J Neurosci 2004, 24: 10530-10541. (Pubitemid 39552638)
18. Aguirre AA, Chittajallu R, Belachew S, Gallo V. NG2-expressing cells in the subventricular zone are type C-like cells and contribute to interneuron generation in the postnatal hippocampus. J Cell Biol 2004, 165: 575-589. (Pubitemid 38679622)
19. Belachew S, Chittajallu R, Aguirre AA, Yuan X, Kirby M, Anderson S, et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 2003, 161(1): 169-186. (Pubitemid 36459089)
20. Matthias K, Kirchhoff F, Seifert G, Huttmann K, Matyash M, Kettenmann H, et al. Segregated expression of AMPA-type glutamate receptors and glutamate transporters defines distinct astrocyte populations in the mouse hippocampus. J Neurosci 2003, 23: 1750-1758. (Pubitemid 36314730)
21. Zhou M, Kimelberg HK. Freshly isolated hippocampal CA1 astrocytes comprise two populations differing in glutamate transporter and AMPA receptor expression. J Neurosci 2001, 21(20): 7901-7908. (Pubitemid 32952749)
22. Bergles DE, Roberts JD, Somogyi P, Jahr CE. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 2000, 405(6783): 187-191. (Pubitemid 30313537)
23. 2+-permeable AMPA receptors. Science 2006, 312: 1533-1537. (Pubitemid 43865894)
24. Tan AM, Zhang W, Levine JM. NG2: a component of the glial scar that inhibits axon growth. J Anat 2005, 207 (6): 717-725. (Pubitemid 43019731)
25. Hampton DW, Rhodes KE, Zhao C, Franklin RJ, Fawcett JW. The responses of oligodendrocyte precursor cells, astrocytes and microglia to a cortical stab injury in the brain. Neuroscience 2004, 127(4): 813-820. (Pubitemid 39099547)
26. Matsumoto H, Kumon Y, Watanabe H, Ohnishi T, Shudou M, Chuai M, et al. Accumulation of macrophage-like cells expressing NG2 proteoglycan and Iba1 in ischemic core of rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 2008, 28(1): 149-163.
27. Wang A, He BP. Characteristics and functions of NG2 cells in normal brain and neuropathology. J Neurol Res 2009, 31(3): 144-150.
28. Drew L, Sellers, Philip J. Horner Instructive niches: environmental instructions that confound NG2 proteoglycan expression and the fate-restriction of CNS progenitors. J Anat 2005, 207: 727-734.
29. Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, et al. Development of NG2 neural progenitor cells requires Olig gene function. Proc Natl Acad Sci U S A 2006, 103: 7853-7858.
30. de Castro R Jr, Tajrishi R, Claros J, Stallcup WB. Differential responses of spinal axons to transection: influence of the NG2 proteoglycan. Exp Neurol 2005, 192: 299-309. (Pubitemid 40341676)
31. Bjartmar C, Trapp BD. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 2001, 14: 271-278. (Pubitemid 32510589)
32. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 2004, 166: 121-131. (Pubitemid 38931922)
33. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120: 393-399. (Pubitemid 27153632)
34. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998, 280: 1610-1613. (Pubitemid 28278256)
35. Raine CS. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J Neuroimmunol 1997, 77: 135-152. (Pubitemid 27312351)
36. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338: 278-285. (Pubitemid 28065253)
37. Wilson HC, Scolding NJ, Raine CS. Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol 2006, 176(1-2): 162-173. (Pubitemid 44080336)
38. Jennings A, Carroll W. Quantification of oligodendrocyte progenitor cells in human and cat optic nerve: implications for endogenous repair in multiple sclerosis. Glia 2010, 58(12): 1425-1436.
39. Trotter J. NG2-positive cells in CNS function and the pathological role of antibodies against NG2 in demyelinating diseases. Neurol Sci 2005, 233(1-2): 37-42. (Pubitemid 40812333)
40. Paintlia AS, Paintlia MK, Singh AK, Singh I. Inhibition of rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis. Mol Pharmacol 2008, 73(5): 1381-1393. (Pubitemid 351574828)
41. Aharoni R, Herschkovitz A, Eilam R, Blumberg-Hazan M, Sela M, Bruck W, et al. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2008, 105(32): 11358-11363.
42. Jiang SC, Ballerini P, Buccella S, Giuliani P, Jiang C, Huang, XJ, et al. Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine. Purinergic Signal 2008, 4(1): 61-71.
43. Kuhlmann T, Remington L, Cognet I, Bourbonniere L, Zehntner S, Guilhot F, et al. Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis. Am J Pathol 2006, 169(2): 584-598. (Pubitemid 44156316)
44. Zhang J, Zhang ZG, Morris D, Li Y, Roberts C, Elias SB, et al. Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis. Neuroscience 2009, 164(4): 1887-1893.
45. Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 2006, 53(7): 696-703.
46. Redwine JM, Armstrong RC. In vivo proliferation of oligodendrocyte progenitors expressing PDGF alpha R during early remyelination. J Neurobiol 1998, 37(3): 413-428. (Pubitemid 28506925)
47. Patel JR, McCandless EE, Dorsey D. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci U S A 2010, 107(24): 11062-11067.
48. Chekenya M, Pilkington G. NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours. J Neurocytol 2002, 31: 507-521. (Pubitemid 37378262)
49. Bouvier C, Bartloi C, Aguirre-Cruz L, Virard I, Colin C, Fernandez C, et al. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells. J Neurosurg 2003, 99: 344-350. (Pubitemid 36903275)
50. Ligon K, Alberta J, Kho A, Weiss J, Kwaan M, Nutt C, et al. The oligodendroglial lineage marker Olig2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 2004, 63: 499-509. (Pubitemid 38669670)
51. Uhrbom L, Hesselager G, Ostman A, Nister M, Westermark B. Dependence of autocrine growth factor stimulation in PDFG-Binduced mouse brain tumor cells. Int J Cancer 2000, 85: 398-406. (Pubitemid 30030415)
52. Hu X, Holland E. Applications of mouse glioma models in preclinical trials. Mut Res 2005, 576: 54-65. (Pubitemid 40982682)
53. Dai C, Celestino J, Okada Y, Louis D, Fuller G, Holland E. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2006, 15: 1913-1925. (Pubitemid 32738621)
54. Shih AH, Holland EC. Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett 2006, 232: 139-147. (Pubitemid 43170963)
55. Schrappe M, Klier F, Spiro R, Waltz T, Reisfeld R, Gladson C. Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. Cancer Res 1991, 51: 4986-4993.
56. Shoshan Y, Nishiyama A, Chang A, Mork S, Barnett G, Cowell J, et al. Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. Proc Natl Acad Sci U S A 1999, 96: 10361-10366. (Pubitemid 29422563)
57. Chekenya M, Hjelstuen M, Enger PO, Thorsen F, Jacob AL, Probst B, et al. NG2 proteogycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin. FASEB J 2002, 16: 586-588.
58. Chekenya M, Enger P, Thorsen F, Tysnes B, Al-Sarraj S, Read T, et al. The glial precursor proteoglycan NG2 is expressed on tumor neovasculature by vascular pericytes in human malignant brain tumours. Neuropathol Appl Neurobiol 2002, 28: 367-380. (Pubitemid 35282452)
59. Wiranowska M, Ladd S, Smith S, Gottschall P. CD44 adhesion molecule and neuroglial proteoglycan NG2 as invasive markers of glioma. Brain Cell Biol 2006, 35: 159-172. (Pubitemid 47630628)
60. Chekenya M, Krakstad C, Svendsen A, Netland I, Staalsen V, Tysnes B, et al. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene 2008, 27: 5182-5194.
61. Staugaitis SM, Trapp BD. NG2-positive glia in the human central nervous system. Neuron Glia Biol 2009, 5(3/4): 35-44.
62. Tillet E, Ruggiero F, Nishiyama A, Stallcup W. The membranespanning proteoglycan NG2 binds to collagens V and VI through the central non-globular domain of its core protein. J Biol Chem 1997, 272: 10769-10776. (Pubitemid 27181090)
63. Hagg T, Portera-Cailliau C, Jucker M, Engvall E. Laminins of the adult mammalian CNS: laminin alpha-2 (merosin M-) chain immunoreactivity is associated with neuronal processes. Brain Res 1997, 764: 17-27. (Pubitemid 27380636)
64. Buttery PC, ffrench-Constant C. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 1999, 14: 199-212. (Pubitemid 29449223)
65. Farin A, Suzuki S, Weiker M, Goldman J, Bruce J, Canoll P. Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 2006, 53: 799-808.
66. Fukushi J, Makagiansar I, Stallcup W. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and α3β1 integrin. Mol Biol Cell 2004, 15: 3580-3590. (Pubitemid 38989698)
67. Eisenmann KM, McCarthy JB, Simpson MA, Keely PJ, Guan JL, Tachibana K, et al. Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol 1999, 1: 507-513. (Pubitemid 129503671)
68. Yang J, Price M, Neudauer C, Wilson C, Ferrone S, Xia H, et al. Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms. J Cell Biol 2004, 165: 881-891. (Pubitemid 38821978)
69. Makagiansar IT, Williams S, Dahlin-Huppe K, Fukushi J, Mustelin T, Stallcup WB. Phosphorylation of NG2 proteoglycan by protein kinase C-α regulates polarized membrane distribution and cell motility. J Biol Chem 2004, 279: 55262-55270. (Pubitemid 40066523)
70. Makagiansar IT, Williams S, Mustelin T, Stallcup WB. Differential phosphorylation of NG2 proteoglycan by ERK and PKCα helps balance cell proliferation and migration. J Cell Biol 2007, 178: 155-165. (Pubitemid 47026410)
71. Goretzki L, Burg MA, Grako KA, Stallcup WB. High affinity binding of bFGF and PDGF-AA to the core protein of the NG2 proteoglycan. J Biol Chem 1999, 274: 16831-16837.
72. Burg MB, Tillet E, Timpl R, Stallcup WB. Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix ligands. J Biol Chem 1996, 271: 26110-26116. (Pubitemid 26347453)
73. Makagiansar IT, Williams S, Mustelin T, Stallcup WB. Differential phosphorylation of NG2 proteoglycan by ERK and PKCα helps balance cell proliferation and migration. J Cell Biol 2007, 178: 155-165. (Pubitemid 47026410)
74. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz D, Demuth T, et al. Migrating glioma cells activate the PI3K pathway and display decreased susceptibility to apoptosis. J Cell Sci 2003, 116: 4409-4417. (Pubitemid 37369596)
75. Chekenya M, Krakstad C, Svendsen A, Netland I, Staalsen V, Tysnes B, et al. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene 2008, 27: 5182-5194.
76. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta catenin signalling: diseases and therapies. Nat Rev Genet 2004, 5: 691-701. (Pubitemid 39150127)
77. Salins P, Shawesh S, He Y, Dibrov A, Kashour T, Arthur G, et al. Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling. Neurosci Lett 2007, 412: 211-216. (Pubitemid 46109146)
78. De Ferrari GV, Chacón MA, Barría MI, Garrido JL, Godoy JA, Olivares G, et al. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by betaamyloid fibrils. Mol Psychiatry 2003, 8: 195-208. (Pubitemid 36315228)
79. Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, Inestrosa NC. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 2004, 297: 186-196. (Pubitemid 38759572)
80. Lie DC, Colamarino SA, Song HJ, Désiré L, Mira H, Consiglio A, et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005, 437: 1370-1375. (Pubitemid 41568684)
81. Teo JL, Ma H, Nguyen C, Lam C, Kahn M. Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation. Proc Natl Acad Sci U S A 2005, 102: 12171-12176. (Pubitemid 41291147)
82. Behrens J, von Kries JP, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996, 382: 638-642. (Pubitemid 26268958)
83. Nusse R. WNT targets. Repression and activation. Trends Genet 1999, 15: 1-3.
84. Brantjes H, Roose J, van De Wetering M, Clevers H. All Tcf HMG box transcription factors interact with Groucho-related corepressors. Nucleic Acids Res 2001, 29: 1410-1419. (Pubitemid 32288486)
85. He P, Shen Y. Interruption of â-catenin signaling reduces neurogenesis in Alzheimer's disease. J Neurosci 2009, 29(20): 6545-6557.
86. Garrido JL, Godoy JA, Alvarez A, Bronfman M, Inestrosa NC. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J 2002, 16: 1982-1984.
87. Salins P, Shawesh S, He Y, Dibrov A, Kashour T, Arthur G, et al. Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling. Neurosci Lett 2007, 412: 211-216. (Pubitemid 46109146)
88. Castelo-Branco G, Rawal N, Arenas E. GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J Cell Sci 2004, 117: 5731-5737. (Pubitemid 40123940)
89. Hattiangady B, Shetty AK. Decreased neuronal differentiation of newly generated cells underlies reduced hippocampal neurogenesis in chronic temporal lobe epilepsy. Hippocampus 2010, 20(1): 97-112.
90. + cells in the rat hippocampus. J Neurosci Res 2009, 87(3): 636-643.
91. During MJ, Spencer DD. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993, 341: 1607-1610. (Pubitemid 23175242)
92. Seifert G, Huttmann K, Schramm J, Steinhauser C. Enhanced relative expression of glutamate receptor 1 flip AMPA receptor subunits in hippocampal astrocytes of epilepsy patients with Ammon's horn sclerosis. J Neurosci 2004, 24: 1996-2003. (Pubitemid 38292813)
93. Seifert G, Schroder W, Hinterkeuser S, Schumacher T, Schramm J, Steinhäuser C. Changes in flip/flop splicing of astroglial AMPA receptors in human temporal lobe epilepsy. Epilepsia 2002, 43 (Suppl 5): 162-167. (Pubitemid 34864226)
94. + channels in astrocytes of mouse hippocampus. Mol Cell Neurosci 2002, 19: 447-458. (Pubitemid 34293465)
95. Jabs R, Pivneva T, Hüttmann K, Wyczynski A, Nolte C, Kettenmann H, et al. Synaptic transmission onto hippocampal glial cells with hGFAP promoter activity. J Cell Sci 2005, 118(Part 16): 3791-3803. (Pubitemid 41309425)
96. Lin SC, Bergles DE. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat Neurosci 2004, 7(1): 24-32. (Pubitemid 38032164)
97. Madesen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 2000, 47: 1043-1049. (Pubitemid 30336212)
98. Jansson L, Wennström M, Johanson A, Tingström A. Glial cell activation in response to electroconvulsive seizures. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(7): 1119-1128.
99. Wennström M, Hellsten J, Ekstrand J, Lindgren H, Tingström A. Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol Psychiatry 2006, 59(2): 178-186. (Pubitemid 43117508)
100. Bolwig TG, Madsen TM. Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis. Acta Psychiatr Scand Suppl 2007, 433: 130-135. (Pubitemid 46114848)
101. Hellsten J, Wennström M, Mohapel P, Ekdahl CT, Bengzon J, Tingstrom A. Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment. Eur J Neurosci 2002, 16: 283-290. (Pubitemid 36160248)